Breed · Goat
Boer: adverse event reports
FDA breed label "Boer" · single-breed animals only
FDA's database holds 124 reports where the animal's breed is given as "Boer", shown here as Boer: 14.9% of reports about goats. Reports on crossbred animals are left out of breed pages.
0 reports arrived in the 12 months to March 2026, and none in the 12 months before. A breed's count mostly mirrors how common the breed is; registration and ownership figures by breed are not public data, so no per-animal rate can be given.
By active ingredient, the drugs named most often are monensin, albendazole and moxidectin. Monensin is named in 23.4% of this breed's reports, a larger share than in reports about all goats (9.9%).
The terms listed most often are death (47.6%), recumbency (10.5%) and depression (9.7%). Death appears in 47.6% of reports, about the same share as in all goat reports (39.7%). 68.2% of reports stating seriousness were classed as serious, against 59.3% for goats overall.
Drugs named most often, by active ingredient
| Active ingredients recorded for the drug | Reports | Share of Boer reports | Share of all goat reports |
|---|---|---|---|
| Monensin | 29 | 23.4% | 9.9% |
| Albendazole | 18 | 14.5% | 8.4% |
| Moxidectin | 15 | 12.1% | 11.4% |
| Fenbendazole | 10 | 8.1% | 5.2% |
| Doramectin | 9 | 7.3% | 3.1% |
| Progesterone | 6 | 4.8% | 2.2% |
| Tilmicosin Phosphate | 4 | 3.2% | 7.5% |
| Tulathromycin | 3 | 2.4% | 3.5% |
| Amprolium | 2 | 1.6% | 1.4% |
| Ceftiofur Crystalline Free Acid | 2 | 1.6% | 0.7% |
| Eprinomectin | 2 | 1.6% | 1.6% |
| Ivermectin | 2 | 1.6% | 9% |
| Ivermectin + Praziquantel | 2 | 1.6% | 0.6% |
| Pyrantel Tartrate | 2 | 1.6% | 0.7% |
| Tylosin | 2 | 1.6% | 1.6% |
| Decoquinate | 1 | 0.8% | 0.8% |
| Florfenicol | 1 | 0.8% | 3.7% |
| Flunixin Meglumine | 1 | 0.8% | 1.7% |
| Fluralaner | 1 | 0.8% | 0.4% |
| Furazolidone | 1 | 0.8% | 0.1% |
Ordered by report count. Differences from the species column often come from body size (which drugs a breed is prescribed) and from how common the breed was in the years a drug sold most. FDA states that these data cannot be used to estimate risk or to compare one product with another. Brand and manufacturer names are masked by FDA in these records.
Signs listed in reports
share of Boer reports listing the termall goat reports
- Death47.6%59
- Recumbency[lying down and unable or unwilling to rise]10.5%13
- Depression[dull, quiet or withdrawn]9.7%12
- Diarrhoea[diarrhea]9.7%12
- Anorexia[not eating]7.3%9
- Ataxia[unsteady, uncoordinated movement]6.5%8
- Ineffective, worms NOS[legacy FDA term: the product did not have the expected effect (worms nos)]6.5%8
- No sign[no clinical sign was reported]6.5%8
- Abortion5.6%7
- Ineffective, parasite(s) NOS[legacy FDA term: the product did not have the expected effect (parasite(s) nos)]4.8%6
- Blindness4%5
- Lack of efficacy - NOS[the product did not have the expected effect]4%5
- Ruminant stomach disorder4%5
- Vocalisation[crying out or unusual noise]4%5
- Weight loss4%5
- Accidental exposure[exposure that was not intended]3.2%4
- Agalactia3.2%4
- Lack of efficacy (bacteria) - NOS[the product did not have the expected effect: target not specified]3.2%4
- Convulsion[seizure]2.4%3
- Death by euthanasia[the animal was euthanized]2.4%3
- Discoloured urine2.4%3
- Hypersalivation[drooling]2.4%3
- Ineffective, stomach worm NOS[legacy FDA term: the product did not have the expected effect (stomach worm nos)]2.4%3
Age and weight
Age of the animal
Weight of the animal
Coloured bar: Boer reports. Grey bar: all goat reports.
Trend and outcomes
Reports by month FDA received them. The newest months are incomplete because FDA posts reports with a delay of three to six months.
Outcome recorded in the report
Beside all goats
| Measure | Boer | All goats |
|---|---|---|
| Reports | 124 | 832 |
| Latest 12 months | 0 | 26 |
| Classed serious, of reports stating it | 68.2% | 59.3% |
| Death or euthanasia recorded, per 1,000 reports | 596.8 | 456 |
Questions about Boer reports
How many FDA adverse event reports involve Boers?
124 reports through March 2026, 14.9% of reports about goats; 0 in the latest 12 months.
Which drugs are named most often in Boer reports?
By active ingredient: monensin (29), albendazole (18), moxidectin (15), fenbendazole (10) and doramectin (9). Brands are masked in the public data.
What signs are reported most for this breed?
death (47.6%), recumbency (10.5%), depression (9.7%), diarrhoea (9.7%) and anorexia (7.3%).
Is the Boer more sensitive to certain drugs?
Report counts cannot answer that. They show what was reported, not what a drug did, and they are not adjusted for how many Boer animals exist or were treated. Breed-related drug sensitivities that are established are described on FDA-approved labels; a veterinarian is the person to ask about an individual animal.
Why are crossbreds not included?
FDA records crossbred animals with one or more component breeds. Counting them under each component would double count, so breed pages use single-breed reports only. Crossbreds remain in the species totals.
How do I report a problem?
Call the drug company using the number on the label, or send Form FDA 1932a to FDA. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Animal & Veterinary adverse event bulk files released 28 Sep 2026, which hold reports FDA's Center for Veterinary Medicine received through 31 Mar 2026. openFDA masks brand and manufacturer names in these files, so drugs are counted by the active ingredients each record discloses and no figure is attributed to a brand, application or company. Ingredient names, and the separate reference lists of approved products, follow the FDA Green Book as of 1 Oct 2026. Breed names are FDA's labels rearranged into everyday order ("Boer" becomes "Boer"). No report text, lot numbers or reporter details are published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.